FDA.reportPublic FDA data

Noxafil 200 MG per 5 ML Oral Suspension

RxCUI
665022
RxNorm name
Noxafil 200 MG per 5 ML Oral Suspension
Display name
Noxafil 200 MG per 5 ML Oral Suspension
Full name
Noxafil 200 MG per 5 ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NOXAFILPOSACONAZOLEMerck Sharp & Dohme LLCb073b082-7b57-4423-8c06-4fd4263d6f842026-02-13Warnings, Adverse reactionsExact identifier
rxcui: 665022

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b073b082-7b57-4423-8c06-4fd4263d6f84NOXAFIL 200 MG in 5 mL Oral Suspension [PSN] · posaconazole 40 MG/ML Oral Suspension [Noxafil] [SBD] · Noxafil 200 MG per 5 ML Oral Suspension [SY] · Noxafil 40 MG/ML Oral Suspension [SY]456These highlights do not include all the information needed to use NOXAFIL safely and effectively. See full prescribing information for NOXAFIL. NOXAFIL ® (posaconazole) injection, for intravenous use NOXAFIL ® (posaconazole) delayed-release tablets, for oral use NOXAFIL ® (posaconazole) oral suspension NOXAFIL ® POWDERMIX (posaconazole) for delayed-release oral suspension Initial U.S. Approval: 200620260213